# Multicenter Single-arm Pilot Study Evaluating Efficacy of Nilotinib in CML Patients With Molecular Relapse After Glivec Discontinuation Within the Context of the STIM Trials (STIM and STIM2)

> **NCT01774630** · PHASE2 · COMPLETED · sponsor: **University Hospital, Bordeaux** · enrollment: 31 (actual)

## Conditions studied

- Leukemia, Myelogenous, Chronic, BCR-ABL Positive

## Interventions

- **DRUG:** Nilotinib

## Key facts

- **NCT ID:** NCT01774630
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04-10
- **Primary completion:** 2020-12-21
- **Final completion:** 2020-12-21
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2022-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01774630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01774630, "Multicenter Single-arm Pilot Study Evaluating Efficacy of Nilotinib in CML Patients With Molecular Relapse After Glivec Discontinuation Within the Context of the STIM Trials (STIM and STIM2)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01774630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*